Observational Study to Develop a Predictive Score for Adverse Events Post ERCP
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
About this trial
The main objective of the study is: the identification of independent factors associated with an increased risk of post-ERCP complications. Other objectives are: the development of a predictive model of events post-ERCP adverse events and its validation; geographic validation of a predictive model already published in the literature using data collected during the study and the evaluation of the rate of post-ERCP AEs in the centers involved in the study.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age >18 years
Patients admitted with hepato-biliary-pancreatic disease or other pathological conditions that require treatment by ERCP
Obtaining informed consent
Disqualifiers
None
Trial population
Patients undergoing ERCP according to normal clinical practice
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
981 Participants
are grouped into 1 trial groupGroup A: Patients undergoing ERCP according to normal clinical practice
Trial outcomes
Primary outcomes
1
post-ERCP complications
Identification of independent factors associated with an increased risk of post-ERCP complications.
Time frame
14 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov